GLC DETERMINATION OF PLASMA DRUG LEVELS AFTER ORAL-ADMINISTRATION OF CLORAZEPATE POTASSIUM SALTS

被引：27

作者：

HOFFMAN, DJ ^{[1
]}

CHUN, AHC ^{[1
]}

机构：

[1] ABBOTT LABS,PHARM PROD DIV,CHICAGO,IL 60064

来源：

关键词：

D O I：

10.1002/jps.2600641017

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1668 / 1671

页数：4

共 9 条

[1] CLORAZEPATE DIPOTASSIUM - NEW BENZODIAZEPINE ANTIANXIETY AGENT
CHARALAMPOUS, KD
TOOLEY, W
YATES, C
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (2-3) : 114 - 118
[2] LEHMANN M, 1968, CAH MED LYON, V44, P2201
[3] PLOTNIKOFF NP, 1973, RES COMMUN CHEM PATH, V5, P128
[4] METABOLIC ALTERATION OF DRUGS
SCHREIBER, EC
[J]. ANNUAL REVIEW OF PHARMACOLOGY, 1970, 10 : 77 - +
[5] SCHWARTZ MA, 1965, J PHARMACOL EXP THER, V149, P423
[6] SILVA JAF, 1966, J PHARM SCI, V55, P692
[7] SILVA JAF, 1964, ANAL CHEM, V36, P2099
[8] WIERSUM J, 1972, CURR THER RES CLIN E, V14, P442
[9] DIAZEPAM METABOLISM DURING CHRONIC MEDICATION - UNBOUND FRACTION IN PLASMA, ERYTHROCYTES AND URINE
ZINGALES, IA
[J]. JOURNAL OF CHROMATOGRAPHY, 1973, 75 (01): : 55 - 78